TOI
NASDAQ
$5.50
Oncology Institute Inc (The) (TOI)
Oncology Institute Inc (ticker: TOI) is a leading healthcare organization focused on revolutionizing cancer care through its extensive network of specialized clinics and innovative treatment methodologies. By harnessing advanced technologies and personalized care strategies, the company aims to significantly improve patient outcomes while emphasizing clinical trials and partnerships with premier research institutions. Positioned to capitalize on the growing demand for advanced cancer therapies, TOI benefits from a solid pipeline and a wealth of oncology expertise, presenting a compelling investment opportunity within the dynamic healthcare landscape.
This company is also listed under the following ticker: TOIIW.
Website: https://theoncologyinstitute.comSector:
Healthcare
Industry:
Medical Care Facilities
Strong Buy
Target: $8.40 (+52.73%)
Market Cap
$566M
P/B Ratio
0.76
Free Cash Flow Yield
-4.55%
Beta (5Y)
1.47
Price Chart
Valuation
Market Cap$566M
P/S1.07
P/B0.76
Profitability
Total Revenue (TTM)$546M
Gross Profit (TTM)$83M
EBITDA-$26M
Profit Margin-1.7%
Operating Margin-4.4%
EPS-$0.45
Financial Health
Debt-to-Equity-482.7%
Free Cash Flow Yield-4.55%
Growth & Risk
Beta (5Y)1.47
Sharpe Ratio0.86